MAPT and Alzheimer disease: Indeed, both recombinant and AD-derived tau can, with varying efficiencies, seed tau pathology in both tau over-expressing transgenic models [8, 9, 19, 23, 37, 43] and non-transgenic models [23, 30, 37, 43, 50].